Related Experiment Video
Updated: Aug 6, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5
Alex von Kriegsheim1, Andrew Pitt, G Joan Grindlay
1The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.
Abstract:
The Raf-MEK-ERK pathway couples growth factor, mitogenic and extracellular matrix signals to cell fate decisions such as growth, proliferation, migration, differentiation and survival. Raf-1 is a direct effector of the Ras GTPase and is the initiating kinase in this signalling cascade. Although Raf-1 activation is well studied, little is known about how Raf-1 is inactivated. Here, we used a proteomic approach to identify molecules that may inactivate Raf-1 signalling. Protein phosphatase 5 (PP5) was identified as an inactivator that associates with Raf-1 on growth factor stimulation and selectively dephosphorylates an essential activating site, Ser 338. The PP5-mediated dephosphorylation of Ser 338 inhibited Raf-1 activity and downstream signalling to MEK, an effect that was prevented by phosphomimetic substitution of Ser 338, or by ablation of PP5 catalytic function. Furthermore, depletion of endogenous PP5 increased cellular phospho-Ser 338 levels. Our results suggest that PP5 is a physiological regulator of Raf-1 signalling pathways.
Insights
Protein phosphatase 5 (PP5) inactivates the Raf-1 kinase, a key component of the Raf-MEK-ERK pathway. PP5 selectively dephosphorylates an activating site on Raf-1, inhibiting downstream signaling and cell fate decisions.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Signal transduction
Background:
- The Raf-MEK-ERK pathway is crucial for cell fate decisions, responding to growth factor and extracellular matrix signals.
- Raf-1 is the initiating kinase in this cascade, directly activated by Ras GTPase.
- Mechanisms of Raf-1 inactivation remain largely uncharacterized.
Purpose of the Study:
- To identify molecules that inactivate Raf-1 signaling using a proteomic approach.
- To elucidate the role of identified molecules in regulating Raf-1 activity.
Main Methods:
- Proteomic analysis to identify Raf-1 interacting proteins.
- Biochemical assays to assess dephosphorylation activity.
- Site-directed mutagenesis to investigate specific phosphorylation sites (Ser 338).
- Cellular experiments involving PP5 depletion and phosphomimetic substitutions.
Main Results:
- Protein phosphatase 5 (PP5) was identified as a Raf-1 inactivator.
- PP5 selectively dephosphorylates the activating site Ser 338 on Raf-1 upon growth factor stimulation.
- PP5-mediated dephosphorylation inhibits Raf-1 activity and downstream MEK signaling.
- Inhibition was reversed by phosphomimetic substitution or loss of PP5 catalytic function.
- PP5 depletion increased cellular phospho-Ser 338 levels, confirming its role.
Conclusions:
- PP5 acts as a physiological regulator of Raf-1 signaling.
- PP5 deactivates the Raf-MEK-ERK pathway by targeting the Ser 338 site on Raf-1.
- Understanding PP5's role provides insights into controlling cell growth and fate.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade

